Yahoo! Finance, CNN Money and Nasdaq publish up-to-date stock data on Gilead Sciences on their websites. Gilead Sciences trades on the Nasdaq stock exchange under ticker symbol GILD. Gilead Sciences is a bio-pharmaceutical company that focuses on treatments for life threatening diseases and conditions, according to Nasdaq.
Yahoo! Finance hosts daily stock prices and after hours price fluctuations along with historical data. Shares in Gilead Sciences traded between $15 and $25 from 2007 to 2012. From 2012 to late 2014, Gilead stock rallied to quadruple in price and, as of October 2015, has not fallen below $94 per share since. The company's market capitalization exceeds $149 billion and reports earnings per share of more than $9.
Based in Foster City, California, Gilead Science operates in dozens of countries, states Nasdaq. The company concentrates on developing and selling drugs to treat HIV and chronic liver conditions associated with hepatitis B and C as well as treatments for cancers and serious heart and lung conditions. Gilead develops its own drugs and treatments and acquires and licenses products developed at other firms. As of Oct. 15, 2015, shares in Gilead closed at $101.64 per share, $16 above its 52 week low but still $22 shy of its high share price for the previous year.